VKH
ZBH icon

Virtu KCG Holdings’s Zimmer Biomet ZBH Stock Holding History

Virtu KCG Holdings’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,407
Closed -$1.6M – 4125
2014
Q1 		$1.6M Buy
17,407
+12,154
+231% +$1.12M 0.02% 860
2013
Q4 		$475K Buy
5,253
+2,678
+104% +$232K 0.01% 2021
2013
Q3 		$205K Buy
+2,575
New +$203K ﹤0.01% 3102

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Virtu KCG Holdings's ZBH Position: Q2 2017 in Review

Virtu KCG Holdings increased its Zimmer Biomet (ZBH) stake by 149% in Q2 2017, buying an estimated $322K and bringing the position to 4,539 shares worth $566K. The position accounts for 0.02% of the portfolio, ranked #1033.

Virtu KCG Holdings first reported a position in ZBH in Q3 2013 and has held it in 14 quarters since. The position peaked at $4.49M in Q2 2014. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Virtu KCG Holdings held 4,539 shares of Zimmer Biomet worth $566K as of Q2 2017.
  • Virtu KCG Holdings bought 2,716 Zimmer Biomet shares in Q2 2017, an estimated $322K.
  • Zimmer Biomet made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #1033 holding.
  • Virtu KCG Holdings first reported a position in Zimmer Biomet in Q3 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's Zimmer Biomet position peaked at $4.49M in Q2 2014.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.